# Trade Mark Journal No.2025/041 10 October 2025

## WO0000001877180 (5)

Office of origin: United States of America

Date of International Registration:3 June 2025
Date of designation in the UK: 3 June 2025

Class 5
  Pharmaceutical preparations for the treatment of ocular diseases and conditions.

EyePoint Pharmaceuticals US, Inc.

Representative: David J. Davis Baker & McKenzie LLP, 300 East Randolph Street, , Suite 5000, Chicago IL 60601, UNITED STATES OF AMERICA